Experience

Abbott Laboratories v. Teva Pharmaceuticals USA, Inc. 

Abbott Laboratories

Teva Pharmaceuticals USA, Inc.

Member of team that represented Abbott Laboratories in district court Hatch-Waxman litigation related to Zemplar® (paricalcitol) for secondary hyperparathyroidism.

Abbott Laboratories v. Teva Pharmaceuticals USA, Inc. , 1:08-cv-06659, N.D. Ill., Judge Kocoras

Related Practices

Global IP Enforcement, Litigation, and Trials

Branded Hatch-Waxman (ANDA) Litigation and Trials

Related Industries

Life Sciences

Pharmaceutical

Related Experiences

Novartis Pharmaceuticals Corporation et al. v. Fresenius Kabi USA, LLC et al.

Novartis Pharmaceuticals Corporation et al.

Rokiot USA, LLC v. BOSCH Software Innovation Corp., et al.

Bosch Software Innovation Corp.

Uniloc USA, Inc. et al. v. Motorola Mobility LLC et al.

Motorola Mobility LLC et al.

Medtronic Vascular Inc. v. Abbott Vascular, Inc.

Abbott Vascular, Inc.

Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al.

Biogen MA Inc. et al.

Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al.

Duchesnay Inc.

AbbVie Inc., et al. v. Aurobindo Pharma U.S.A., Inc. et al.

AbbVie Inc.

Rocket Pharmaceuticals, Inc. v. Lexeo Therapeutics, Inc., et al.

Rocket Pharmaceuticals, Inc.

Regenxbio, Inc. et al. v. Sarepta Therapeutics, Inc. et al.

Sarepta Therapeutics, Inc. et al.

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.